Main Industry
Health Care
Main Product/Service
SurgMate’s product line includes a Thyroid Nodule Biopsy & Ablation Training Platform, featuring modular thyroid models, temperature monitoring, and “Danger Triangle” alerts to simulate realistic procedure practice.
They also provide custom medical simul
They also provide custom medical simul
The content above was translated by Ai
Founded Year
2018
Unified Business No.
50840887
Status
Active
Number of Employees
0
Total Paid-in
Capital
56,440,000 (NT$)
Location of Company
Taiwan
, New Taipei City
Overseas Development
United States of America
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
SurgMate Co., Ltd., founded in 2018, is a Taiwan‑based company that develops immersive medical simulation platforms. With over 20 years of experience in medical engineering, the company integrates software, hardware, and clinical expertise to build highly realistic and modular training solutions for healthcare professionals, particularly in minimally invasive surgery (MIS) and point‑of‑care ultrasound (POCUS).
The content above was translated by Ai
